Kaitlyn Teafatiller, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 110 Curtis Ln, Howe, TX 75459 Phone: 512-738-9727 |
News Archive
​Smokers who've received a clean bill of health from their doctor may believe cigarettes haven't harmed their lungs. However, researchers at Weill Cornell Medical College have found that even smokers who seem healthy have damaged airway cells, with characteristics similar to cells found in aggressive lung cancer.
In the November 1st issue of G&D, a team of scientists led by Dr. Anil Rustgi (UPENN) presents an innovative new model of esophageal cancer, which holds great promise as an experimental platform to investigate the etiology and possible treatment of this devastating disease.
Portola Pharmaceuticals, Inc. today announced that it has initiated its first in human Phase 1 trial in healthy volunteers of PRT062607, a novel, oral Syk-specific kinase inhibitor in development to treat chronic inflammatory diseases, including rheumatoid arthritis (RA), and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. In preclinical in vivo models of RA, PRT062607 was shown to reduce inflammation in a dose-dependent manner.
Scientists from 11 land-grant institutions and Brigham Young University are working together to help parents motivate children to boost calcium intake to strengthen bones and prevent bone fractures from occurring later in life.
› Verified 7 days ago